Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2013 08:30 ET | Source: Nuvilex, Inc.

Nuvilex, Inc.'s Phase III Pancreatic Cancer Trials Could Address New Law's Call for Progress

NEW YORK, NY--(Marketwired - Jun 24, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has a great opportunity to demonstrate and showcase its encapsulation technology in its upcoming Phase III clinical trials...